术前左心室大小及其术后缩小程度与二尖瓣成形早期预后的相关性研究

目的分析影响退行性二尖瓣反流行成形术早期预后的危险因素。方法回顾性分析2011年1～11月在北京阜外心血管病医院行二尖瓣成形术的二尖瓣退行性变患者,入组患者132例,随访患者114例（86．4％）,平均年龄（51．21±12．78）岁,其中男76例（66．7％）、女38例（33．3％）,通过回访成形术早期的效果对术前危险因素进行分析。结果入选患者合并心房颤动25例（21．9％）,术前射血分数63．88％±6．93％,术前超声心动图提示左心室舒张期末内径指数（31．61±5．51）mm／m^2,合并i尖瓣关闭不全者56例（49．1％）,其中34例（29．8％）同期行三尖瓣成形术,10例（8．8％）应用三尖瓣成形环。术后死亡2例,再次行二尖瓣置换术或成形术2例,超声心动图复查提示二尖瓣中量及以上反流15例。影响二尖瓣成形早期预后的危险因素包括合并心房颤动（36．8％vs．18．9％,P=0．035）、较大的左心室舒张期末内径指数[（34．02±3．76）mm／m^2 vs．（31．15±5．68）mm／m^2,P=-0．042]、功能性二尖瓣反流（15．8％vs．1．1％,P=0．007）。多因素分析结果显示手术前后左心室内径改变（主要是缩小）越大,术后事件发生率降低[HR0．002,95％CI（〈0．001,0．570）,P=0．031]。结论对于二尖瓣退行性反流的患者,术前左心室扩张是影响二尖瓣成形术早期预后的独立危险因素,而此类患者中,左心室内径明显缩小者,术后事件发生率降低。     

成形环在三尖瓣成形术治疗三尖瓣关闭不全中的临床应用

目的 观察利用人工瓣环行三尖瓣成形术治疗风湿性心脏病继发性三尖瓣关闭不全患者的近、中期效果. 方法 2009年12月至201 1年9月四川省简阳市人民医院共有41例风湿性心脏病患者接受左心瓣膜置换术并同期置人人工瓣环行三尖瓣成形术,其中男12例、女29例,平均年龄49(21～67)岁.术前合并心房颤动38例,合并左心房血栓13例;三尖瓣微量反流2例,轻度反流5例,中度反流11例,重度反流23例;行二尖瓣置换术28例,二尖瓣+主动脉瓣置换术13例.所有患者术后均经门诊随访(术后每3个月门诊复查1次),术后6个月复查心脏彩色超声心动图观察三尖瓣反流情况. 结果 术后心功能较术前改善2～3级,心功能Ⅰ级和Ⅱ级共39例,差异有统计学意义(P＜0.05);全组患者随访6～27个月,随访期内无死亡.术后6个月心脏彩色超声心动图检查提示:三尖瓣反流程度较术前明显减轻,微量反流和轻度反流共39例,差异有统计学意义(P＜0.05);术后右心测值较术前明显缩小,右心室横径由术前20 mm降至术后17mm,差异有统计学意义(P＜0.05). 结论 利用人工瓣环行三尖瓣成形术治疗继发性三尖瓣关闭不全,其近、中期疗效明确,远期疗效需要继续随访观察.     

改良三尖瓣成形环技术治疗继发性三尖瓣关闭不全的中期效果

目的 总结改良三尖瓣环成形技术的近、中期疗效.方法 2002年8月至2007年12月,连续158例左心系统瓣膜病变合并三尖瓣关闭不全患者行三尖瓣环成形手术治疗.158例患者中,男74例,女84例;年龄(47.3±12.0)岁.肺动脉收缩压(53.4±19.8)mm Hg(1 mm Hg =0.133 kPa).三尖瓣轻度反流患者66例(41.8％),中度反流54例(34.2％),重度反流38例(24.0％).术前轻度反流组三尖瓣瓣口直径(38.2±4.9) mm,中度反流组(47.0±11.6) mm,重度反流组(44.5±8.9) mm,P＜0.001.轻、中、重度反流组左心室射血分数分别为0.59±0.08、0.59±0.06、0.58±0.09,差异无统计学意义,P=0.73.三尖瓣成形手术适应证为中-大量三尖瓣反流或中度以上肺动脉高压病例(肺动脉收缩压＞40 mm Hg).应用Cosgrove-Edwards成形环进行改良三尖瓣环成形术,在经典术式基础上尽可能采用小号三尖瓣成形环和隔瓣部分固定技术.通过多元回归和生存分析方法,评价近、中期疗效.结果术后少、中、大量反流组病例三尖瓣环缩小值分别为(12.4±5.6) mm、(20.8±11.5)mm、(18.6±8.3) mm,三尖瓣环少量反流组瓣口直径环缩幅度显著小于中、重度反流组(P＜0.001).术后早期中量反流组1例患者死亡.术后157例患者获得中期随访,随访中位数为49.1个月.随访期间3例出现三尖瓣中、大量反流,其中,术前中度反流组1例,重度反流组2例,组间差异无统计学意义,P=0.06.中期随访中9例死亡,其中术前轻度反流组3例,中度反流组2例,重度反流组4例,组间差异无统计学意义,P=0.10.结论 应用Cosgrove-Edwards成形环进行改良三尖瓣环成形术治疗左心系统瓣膜病变合并三尖瓣关闭不全中期效果良好.     

以三尖瓣瓣环径作为三尖瓣成形手术指征的初步临床观察

目的初步观察采用三尖瓣瓣环径作为三尖瓣成形术指征是否有助于减少二尖瓣置换术（MVR）患者术后中重度三尖瓣反流（TR）的发生。方法选择2005年4月至2006年6月期间我科56例术前无或轻度TR的MVR患者纳入研究。以三尖瓣瓣环径/体表面积≥21mm/m2将患者分为三尖瓣成形组（TA组）和非三尖瓣成形组（NTA组）。TA组：22例,男8例,女14例;年龄45.0±7.7岁;三尖瓣瓣环径36.8±3.8mm,体表面积1.57±0.15m2;心功能分级（NYHA）级18例,～级4例;窦性心律2例,心房颤动20例。NTA组：34例,男9例,女25例;年龄42.9±11.0岁;三尖瓣瓣环径28.5±4.4mm,体表面积1.58±0.13m2;心功能分级级28例,～6例;窦性心律9例,心房颤动25例。TA组患者采用Kay法施行三尖瓣成形术。术后随访及术后6个月完成超声心动图检查。结果56例患者术后均康复出院。术后随访11.0±2.4个月,除2例外54例患者完成术后6个月超声心动图复查。两组患者一般临床特征比较差异无统计学意义（P〉0.05）。与NTA组比较,术前TA组患者右房径（49.3±7.0mm）、三尖瓣瓣环径较大（36.8±3.8mm）,有三尖瓣反流的患者较多（P〈0.05）,术后TA组患者右房径（44.1±8.9mm）、三尖瓣瓣环径（28.9±6.1mm）明显缩小,三尖瓣反流程度明显改善（P〈0.05）。NTA组患者术前、术后右房径、三尖瓣瓣环径和三尖瓣反流程度变化不明显（P〉0.05）,有3例患者出现TR。结论对术前无或轻度TR的MVR患者,采用三尖瓣瓣环径作为三尖瓣成形手术指征可能有助于减少这些患者术后中-重度TR的发生。     

二尖瓣成形术在感染性心内膜炎二尖瓣关闭不全治疗中的应用

目的评价二尖瓣成形术治疗感染性心内膜炎二尖瓣关闭不全的疗效。方法自2002年3月至2012年1月共有33例感染性心内膜炎二尖瓣关闭不全患者在北京阜外心血管病医院接受二尖瓣成形术,其中男23例、女10例,年龄10～67（35.7±17.8）岁。13例有心脏基础解剖病变。术前二尖瓣轻度反流5例,中度反流15例,重度反流13例。心功能分级（NYHA）Ⅰ级5例,Ⅱ级23,Ⅲ级4例,Ⅳ级1例。所有患者均行二尖瓣成形术,活动期手术14例。同期行主动脉瓣置换术6例,三尖瓣成形术5例,冠状动脉旁路移植术1例,左心房粘液瘤切除术1例,主动脉窦瘤修补术1例。成形方法包括心包修补穿孔5例,瓣叶切除缝合17例,双孔法成形3例,腱索转移及人工腱索5例,15例使用人工成形环。结果围术期死亡1例,于术后7 d并发急性心肌梗死死亡。32例存活患者均康复出院。出院前超声心动图提示：左心室舒张期末内径、左心房内径分别为（48.9±7.6）mm及（31.7±7.4）mm,较术前有明显改善（P=0.000）。32例患者完成随访,随访时间6～125（73.0±38.6）个月。随访期间无死亡,无心内膜炎复发及出血栓塞等并发症。1例术后3年因二尖瓣狭窄而行二尖瓣机械瓣置换术。心功能分级（NYHA）Ⅰ级25例,Ⅱ级5例,Ⅲ级2例。二尖瓣有少量反流4例,中量反流1例,无反流26例;舒张期二尖瓣流速偏快（1.7 m/s）1例,主动脉瓣中量反流1例。左心室舒张期末内径及左心房内径与术后早期比较差异无统计学意义,射血分数较术后早期改善（60.9%±6.6%vs.57.5%±6.7%;P=0.043）。结论二尖瓣成形术治疗感染性心内膜炎二尖瓣关闭不全疗效可靠,左心房、左心室内径显著减小,心功能改善明显。     

经主动脉路径同期手术修复主动脉根部或主动脉瓣病变合并的中度功能性二尖瓣关闭不全

目的探讨经主动脉路径同期手术修复主动脉根部或主动脉瓣病变合并的中度功能性二尖瓣关闭不全的手术技术,分析随访结果。方法回顾性分析2006年1月至2012年6月新华医院25例主动脉根部或主动脉瓣病变合并中度功能性二尖瓣关闭不全患者经手术治疗的临床资料,其中男18例,女7例;年龄42～75（57．9±9．6）岁。所有患者除主动脉根部或主动脉瓣病变均合并中度功能性二尖瓣关闭不全。Carpentier分型均为Ⅰ型。手术方法均在全身麻醉低温体外循环下行主动脉瓣置换或主动脉根部置换加二尖瓣成形术（均为经主动脉切口交界缝合成形）。通过门诊复查,电话等随访观察,评价二尖瓣及心脏结构和功能。结果术中食管超声心电图提示2例有残余微量反流,其余23例患者无反流,无瓣膜狭窄,成形效果满意。全组患者无死亡。术后复查超声心动图提示：左心房内径、左心室舒张期末内径与术前比较明显缩小（t=4．086,P=0．000;t=4．442,P=0．000）;左心室射血分数与术前比较有所降低（t=3．671,P=0．001）。术后二尖瓣瓣环直径与术前比较缩小[（32．4±3．6）mm vs．（35．6±6．4）mm]。术后二尖瓣瓣口压差[（1．4±0．7）mmHg vs．（1．5±0．7）mmHg],二尖瓣瓣口峰值压差[（3．7±2．2）mmHg vs．（3．3±1．5）mmHg]与术前比较差异无统计学意义（P〉0．05）。患者出院后随访23例,随访率92％,随访时间7～92（50．4±25.3）个月;2例失访。随访期间出现二尖瓣轻度反流3例。最后一次随访二尖瓣瓣环直径（33．9±4．6）mm,二尖瓣瓣口压差（1．3±0．6）mmHg,二尖瓣瓣口峰值压差（3．6±2．3）mmHg。结论主动脉瓣或主动脉根部手术时,经主动脉路径修复中度功能性二尖瓣关闭不全安全、方便、有效。     

二尖瓣成形术治疗中重度黏液样退行性二尖瓣关闭不全远期疗效的影响因素

目的 探讨并总结二尖瓣成形术治疗中、重度黏液样退行性二尖瓣关闭不全远期疗效的影响因素.方法 分析1993年1月至2008年1月261例因中、重度黏液样退行性二尖瓣关闭不全行二尖瓣成形术的患者临床资料和随访资料.结果 围术期死亡7例,生存254例,生存患者二尖瓣成形效果良好.230例随访≥36个月,平均(77.3±30.3)个月,随访率90.6％；24例失访.多因素Cox regression分析显示,年龄≥60岁、左心室射血分数＜0.50、同期行冠状动脉旁路移植术是术后远期死亡的独立危险因素；左心室射血分数＜0.50、心功能(NYHA)Ⅲ-Ⅳ级、前瓣叶脱垂是术后远期二尖瓣再次中、重度反流的独立危险因素,成形环或塑形带成形是术后远期二尖瓣再次中、重度反流的保护因素.结论 年龄≥60岁、左心室射血分数＜0.50、同期行冠状动脉旁路移植术、心功能分级Ⅲ-Ⅳ级、前瓣叶脱垂、成形环或塑形带成形等因素与中、重度黏液样退行性二尖瓣关闭不全患者二尖瓣成形术后远期不良事件密切相关.     

中重度三尖瓣关闭不全行三尖瓣成形术中应用EdwardsMC3环的近中期效果分析

目的探讨中重度三尖瓣关闭不全行三尖瓣成形术中应用Edwards MC3环的近中期效果。方法选取2016-01—2017-10间郑州市第七人民医院收治的60例中重度三尖瓣关闭不全患者,在行三尖瓣成形术中应用Edwards MC3环。观察术前及术后患者的心功能指标及三尖瓣反流程度。结果术后及术后1周、6个月,患者的心功能指标及三尖瓣反流程度均较术前显著改善,差异有统计学意义(P0.05)。结论在中重度三尖瓣关闭不全行三尖瓣成形术中,应用Edwards MC3环,可有效改善患者的心功能指标和三尖瓣反流程度。     

缘对缘瓣叶缝合技术治疗退行性二尖瓣关闭不全的临床分析

目的 探讨缘对缘瓣叶缝合技术的特点及其治疗退行性二尖瓣关闭不全的疗效.方法 回顾性分析2000年1月至2009年1月58例因退行性二尖瓣关闭不全行缘对缘瓣叶缝合技术治疗的患者的临床资料.58例患者中男性32例,女性26例;年龄43～65岁,平均(56±6)岁.二尖瓣中度反流18例,重度反流40例.前瓣叶脱垂50例,双瓣叶脱垂8例.58例患者均采用缘对缘瓣叶缝合技术,其中44例患者同期行瓣环成形术.通过电话、信件、门诊复查等方式进行随访.结果 围手术期无死亡和严重并发症发生.58例患者术后复查经胸超声心动图提示左心室、左心房明显缩小(P均＜0.05),二尖瓣反流明显改善(无反流9例、微量反流30例、轻度反流19例),且无狭窄发生.58例患者术后随访24～95个月,平均(58±20)个月.随访期间死亡2例,死亡原因均为非心源性.二尖瓣重度反流1例、中度反流3例,无狭窄发生.术后5年二尖瓣再次中重度反流免除率为91.9％.随访中根据手术时是否行瓣环成形术,将58例患者分成缘对缘瓣叶缝合组14例和缘对缘瓣叶缝合+瓣环成形组44例,生存分析显示,缘对缘瓣叶缝合+瓣环成形组患者术后远期二尖瓣再次中重度反流免除率更高(x2=4.034,P=0.045).结论 缘对缘瓣叶缝合技术治疗退行性二尖瓣关闭不全围手术期及术后远期成形效果良好,与瓣环成形技术联合应用可提高术后远期成形效果.     

二尖瓣成形术治疗132例中、重度二尖瓣关闭不全患儿的中期疗效

目的 探讨儿童中重度二尖瓣关闭不全成形术的手术方法及治疗效果.方法 回顾性分析132例中重度二尖瓣关闭不全患儿资料,年龄2个月～6岁,平均(18.9±7.2)个月;体质量4～21kg,平均(11.3±4.8)kg.先天性心脏病126例,感染性心内膜炎5例,马方综合征1例.全组患儿均在全麻中低温体外循环下,采用瓣环环缩术、人工瓣环成形术、瓣叶裂缺修补术、后瓣矩形或三角形切除成形术、腱索折叠等个体化的二尖瓣综合成形技术,同期矫治合并的心脏畸形,术中经食管超声(TEE)检查评价成形效果.结果 全组患儿术中TEE示131例无反流或轻度反流;1例中度反流再次行体外循环下二尖瓣成形.术中平均体外循环(80.0±31.1) min,平均主动脉阻断(48.0±17.9) min.早期死亡3例,病死率2.3％,其中2例为完全型房室间隔缺损患儿,分别于术后第7天死于心力衰竭,术后第2天死于低心排血量综合征;1例为大型室间隔缺损合并重度肺动脉高压患儿,术后1个月死于肺部感染.129例成功治愈出院,术后呼吸机辅助(34.4±31.9)h,术后住院(9.0±5.4)天.完整随访122例,时间2～74个月,平均(40.5±8.3)个月.随访期间无死亡.复查超声心动图提示中度反流7例,重度反流3例,4例患儿再次行二尖瓣成形或二尖瓣置换术.本组患儿5年生存率97.7％,免除再手术率92.0％.结论 儿童中重度二尖瓣关闭不全应早期行手术治疗,合并其他心脏畸形需同期矫治,手术治疗的早、中期效果满意.术中根据二尖瓣的具体病变情况,采取个体化的综合成形方法是成功治疗儿童中重度二尖瓣关闭不全的关键.     

应用彩色多普勒对二尖瓣置换术后三尖瓣功能的远期随访

目的应用彩色多普勒超声评价二尖瓣置换术后远期三尖瓣功能及形态变化。方法对接受二尖瓣置换术的903例病人术后三尖瓣功能进行了2～9年,平均(3.6±2.4)年的跟踪观察。所有病例术前均有不同程度的三尖瓣环扩大或关闭不全,其中未行三尖瓣成形术者201例;行Kay或改良DeVega成形术者686例;三尖瓣成形术同时加成形环者16例。结果未行三尖瓣成形术者术后2～3年有46例出现三尖瓣重度关闭不全;行Kay或改良DeVega成形术者,术后3～5年150例出现中重度三尖瓣关闭不全;三尖瓣成形术同时加成形环者仅1例术后2年出现三尖瓣轻-中度关闭不全。结论二尖瓣置换术后远期三尖瓣功能性关闭不全与三尖瓣环扩大、右心功能损害和严重肺动脉高压有关,三尖瓣环扩大是其重要的原因。对二尖瓣置换术者,手术中一旦发现有三尖瓣环扩大,即使无三尖瓣关闭不全,亦应行三尖瓣成形术,重度三尖瓣关闭不全、瓣环明显扩大者最好在环缩术的同时加成形环。     

Partial tricuspid valve transfer for repair of mitral insufficiency due to ruptured chordae tendineae

BACKGROUND: A new technique is suggested for the reconstructive surgical treatment of mitral regurgitation. It involves partial transfer of the tricuspid valve of the patient to the mitral valve, in order to provide chordae to correct anterior leaflet prolapse of the mitral valve, secondary to rupture of the chordae tendineae. METHODS: From January 1991 to May 1997, 20 patients with mitral insufficiency due to rupture of the chordae were operated on. The prevailing cause was myxomatous degeneration (70%). Patients were in New York Heart Association functional class III and IV. RESULTS: There were no hospital deaths. Two patients were reoperated on. Eighteen patients (90%) are alive with their own valves (class I and II). Doppler echocardiogram mean values were: ejection fraction, 0.65; left atrial diameter, 4.2 cm; mitral area, 2.4 cm2; mitral transvalvular gradient, 3.3 mm Hg. No regurgitation or mild regurgitation was observed in 16 (94.1%) of the 17 cases evaluated. Mean tricuspid valvular area was 3.3 cm2. In all cases, no tricuspid regurgitation was present or it was mild. CONCLUSIONS: Partial transfer of the tricuspid valve to the mitral valve is an effective procedure for the surgical treatment of mitral valve insufficiency secondary to ruptured chordae tendineae of the anterior leaflet.     

Aortic valve replacement for aortic stenosis in patients with concomitant mitral regurgitation: should the mitral valve be dealt with?

Co-existent mitral regurgitation may adversely influence both morbidity and mortality in patients undergoing aortic valve replacement for severe aortic stenosis. Whilst it is accepted that concomitant mitral intervention is required in severe, symptomatic mitral regurgitation, in cases of mild–moderate non-structural mitral regurgitation, improvement may be seen following aortic valve replacement alone, avoiding the increased risk of double-valve surgery. The exact benefit of such a conservative approach is, however, yet to be adequately quantified. We performed a systematic literature review identifying 17 studies incorporating 3053 patients undergoing aortic valve replacement for aortic stenosis with co-existing mitral regurgitation. These were meta-analysed using random effects modelling. Heterogeneity and subgroup analysis were assessed. Primary end points were change in mitral regurgitation severity and 30-day, 3-, 5- and 10-year mortality. Secondary end points were end-organ dysfunction (neurovascular, renal and respiratory), and the extent of ventricular remodelling following aortic valve replacement. Our results revealed improvement in the severity of mitral regurgitation following aortic valve replacement in 55.5% of patients, whereas 37.7% remained unchanged, and 6.8% worsened. No significant difference was seen between overall data and either the functional or moderate subgroups. The overall 30-day mortality following aortic valve replacement was 5%. This was significantly higher in moderate–severe mitral regurgitation than nil–mild mitral regurgitation both overall (p = 0.002) and in the functional subgroup (p = 0.004). Improved long-term survival was seen at 3, 5 and 10 years in nil–mild mitral regurgitation when compared with moderate–severe mitral regurgitation in all groups (overall p < 0.0001, p < 0.00001 and p = 0.02, respectively). The relative risk of respiratory, renal and neurovascular complications were 7%, 6% and 4%, respectively. Reverse remodelling was demonstrated by a significant reduction in left-ventricular end-diastolic diameter and left-ventricular mass (p = 0.0007 and 0.01, respectively), without significant heterogeneity. No significant change was seen in left-ventricular end-systolic diameter (p = 0.10), septal thickness (p = 0.17) or left atrial area (p = 0.23). We conclude that despite reverse remodelling, concomitant moderate–severe mitral regurgitation adversely affects both early and late mortality following aortic valve replacement. Concomitant mitral intervention should therefore be considered in the presence of moderate mitral regurgitation, independent of the aetiology.     

Post-mitral valve repair systolic anterior motion produced by non-obstructive septal bulge

Objective: Systolic anterior motion (SAM) may rarely occur after mitral valve reconstruction due to different anatomic factors. Several techniques have been described to reduce the incidence of post-repair SAM, e.g. leaflet sliding plasty. However, SAM can still occur after these special procedures. We reviewed data of patients developing SAM with significant mitral regurgitation due to non-obstructive septal bulge. Methods: During a 2-year period mitral valve repair was performed in 358 patients. Five of 358 (1.4%) patients with a mean age of 52±10.5 years developed post-repair SAM with severe mitral insufficiency due to non-obstructive septal bulge. Data of these patients were analyzed retrospectively and controlled after a mean follow-up of 18±2.7 months. Results: Preoperative echocardiography showed end-diastolic septum diameter of 7, 10, 10, 11 and 15 mm. The ratio between end-diastolic septum diameter and free wall diameter was 1 in four patients and 1.25 in one patient. There was no left ventricular outflow tract obstruction (LVOT). Intraoperative data revealed large myxomatous anterior (four patients) and posterior (three patients) leaflets. Quadrangular resection of posterior leaflet was carried out in four patients and sliding plasty in one patient. Cause for post-repair mitral regurgitation was a non-obstructive septal bulge. During a second pump run septal bulge was resected. Mean aortic cross-clamp time and cardiopulmonary bypass time for this procedure was 15±1.4 and 28±3.1 min, respectively. Mitral regurgitation disappeared in all patients immediately after this procedure. The grade of mitral regurgitation at follow-up was 0–1 in all patients. One patient had subaortic gradient of 36 mmHg. Conclusions: If mitral regurgitation occurs after primary successful mitral repair, septum bulge should always be considered as the primary cause for SAM even there is no preoperative gradient in LVOT. Before performing time-consuming corrective operations to relieve SAM, a septum resection should be carried out during a short second pump run.     

"缘对缘"瓣膜成形术在先天性心脏病合并重度三尖瓣关闭不全中的应用

目的 总结运用"缘对缘"成形技术治疗先天性心脏病病人的重度三尖瓣关闭不全的效果.方法 2001年4月至2010年3月,对14例先大性心脏病合并重度三尖瓣关闭不全病人采用常规三尖瓣瓣环成形和"缘对缘"技术行三尖瓣成形.年龄7～62岁,平均(31.2±16.1)岁.先大性心脏畸形包括继发孔房间隔缺损6例,房室管畸形5例,继发孔房间隔缺损合并二尖瓣关闭不全2例,三房心1例.结果 14例出院时均无不适,无住院死亡及术后并发症.术后超声心动图检查示三尖瓣关闭不全无或微量11例,轻度3例.随访3～97个月,平均(51.6±26.8)个月.随访时超声心动图检查示均无三尖瓣狭窄,三尖瓣关闭不全无或微量5例,轻度8例,中度1例.结论 "缘对缘"成形技术纠治先天性心脏病合并重度三尖瓣关闭不全简单、有效.     

Tricuspid regurgitation. A comparison of nonoperative management, tricuspid annuloplasty, and tricuspid valve replacement.

The best means of managing tricuspid regurgitation associated with mitral or mitral and aortic valve disease is still to be determined. During the period 1972 to 1974, we treated 76 patients who had tricuspid regurgitation along with associated valvular dysfunction. Patients with mold regurgitation were treated conservatively, those with moderate regurgation underwent annuloplasty, and those with severe regurgitation had tricuspid valve replacement. We found the results to be less satisfactory in the group treated by annuloplasty than in the other two groups. We still manage conservatively those patients with mild regurgitation, but we believe it appropriate to replace the valve in an increasing number of subjects who have tricuspid regurgitation of moderate severity.     

Transcatheter aortic valve replacement in patients with severe mitral or tricuspid regurgitation at extreme risk for surgery

Objectives

Patients with symptomatic severe aortic stenosis and severe mitral regurgitation or severe tricuspid regurgitation were excluded from the major transcatheter aortic valve replacement trials. We studied these 2 subgroups in patients at extreme risk for surgery in the prospective, nonrandomized, single-arm CoreValve US Expanded Use Study.

The degree of newly emerging mitral regurgitation during off-pump coronary artery bypass is predicted by preoperative left ventricular function

Purpose During off-pump coronary artery bypass (OPCAB), the displacement of the heart causes mitral regurgitation. We hypothesized that patients with impaired left ventricle (LV) function would be more prone to develop mitral regurgitation, due to further LV end-diastolic pressure elevation and mitral annulus distortion. Therefore, in this study, we examined the relationship between LV function and the severity of mitral regurgitation. Methods We studied 41 patients undergoing elective OPCAB. LV function was evaluated by LV ejection fraction (LVEF), serum brain natriuretic peptide (BNP) levels, the Tei index (myocardial performance index) and mitral inflow propagation velocity (Vp). Results Among all of the anastomoses performed mitral regurgitation was most severe during anastomosis of the left circumflex artery (LCX) territory (P < 0.001). Twenty-five patients (61%) had no to mild mitral regurgitation during anastomosis of the LCX territory (M-MR group) and 16 patients (39%) had moderate to severe mitral regurgitation during anastomosis of the LCX territory (S-MR group). There were significant differences between these groups in preoperative serum BNP levels (median, 26 pg·ml⁻¹ interquartile range [IQR, 14 to 75 pg·ml⁻¹] versus median, 173 pg·ml⁻¹ [IQR, 91 to 296 pg·ml⁻¹]; P < 0.001), Tei index values (median, 0.35; [IQR, 0.27 to 0.41] versus median, 0.53 [IQR, 0.47 to 0.57]; P < 0.001), and Vp (median, 63 cm·s⁻¹; [IQR, 57 to 72 cm·s⁻¹] versus median, 47 cm·s⁻¹; [IQR, 40 to 57 cm·c⁻¹]; P = 0.008), while there was no significant difference in LVEF between the patients in the M-MR group and those in the S-MR group. Conclusion Preoperative LV dysfunction is a predictor of severe mitral regurgitation during OPCAB. When poor LV function is suggested, it is necessary to be prepared for further hemodynamic deterioration caused by mitral regurgitation.